SUPPLEMENTARY MATERIALS AND METHODS

Samples
Venous blood (0.9 ml) was collected from the cervical or saphenous vein with 0.1 ml of 3.8% sodium citrate using a 23-gauge needle and a 1-ml syringe. The blood samples were centrifuged at 2,000 × g for 5 min at room temperature. Platelet poor plasma (PPP) samples were cautiously collected without disturbing the buffy coat and subjected to coagulation-fibrinolysis tests. The remainder of the PPP samples were stored at 4°C. To measure MP-TF activity, 125 µl of the PPP was centrifuged at 13,000 × g for 2 min at 4°C within 24 hr from the storage at 4°C to remove platelets and cellular fragments; 100 µl of the supernatant (platelet free plasma: PFP) was frozen at -80°C. All frozen samples were thawed once and analyzed within a year of freezing.
Measurement of MP-TF activity
MP-TF activity was measured using the FXa generation assay according to previously described procedures [1] with slight modifications; 100 µl of PFP samples were thawed at 37°C, and the MPs were isolated by centrifuging at 20,600 × g for 20 min at 4°C. The supernatants were removed and were used as a negative control. Then, 900 µl of tris-buffered saline (TBS) was added to both the MPs-containing pellet and the supernatant, followed by another centrifugation under the same conditions. After the supernatants were removed, the pellets were resuspended with 50 µl of TBS. A total of 40 µl of the MP suspension and the control were seeded into a 96-well plate, and then 60 µl of coagulation factor mixture [TBS with recombinant human activated Factor VII 
